Winslow Evans & Crocker’s Alaunos Therapeutics TCRT Stock Holding History

Winslow Evans & Crocker’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5	Closed	-$3K	–	1151
2020 Q2	$3K	Hold	5	–	–	﹤0.01%	993
2020 Q1	$2K	Hold	5	–	–	﹤0.01%	1062
2019 Q4	$4K	Hold	5	–	–	﹤0.01%	1027
2019 Q3	$4K	Hold	5	–	–	﹤0.01%	1019
2019 Q2	$6K	Buy	+5	New	+$3.44K	﹤0.01%	955
2018 Q2	–	Sell	-13	Closed	-$7.84K	–	1168
2018 Q1	$7.84K	Hold	13	–	–	﹤0.01%	837
2017 Q4	$8.28K	Hold	13	–	–	﹤0.01%	845
2017 Q3	$12.3K	Hold	13	–	–	﹤0.01%	780
2017 Q2	$12.4K	Hold	13	–	–	﹤0.01%	868
2017 Q1	$12.7K	Hold	13	–	–	﹤0.01%	834
2016 Q4	$10.7K	Hold	13	–	–	﹤0.01%	863
2016 Q3	$11.3K	Hold	13	–	–	﹤0.01%	873
2016 Q2	$11K	Hold	13	–	–	﹤0.01%	852
2016 Q1	$14.8K	Hold	13	–	–	﹤0.01%	781
2015 Q4	$16.6K	Hold	13	–	–	﹤0.01%	791
2015 Q3	$18K	Hold	13	–	–	0.01%	750
2015 Q2	$24K	Hold	13	–	–	0.01%	720
2015 Q1	$21.5K	Hold	13	–	–	0.01%	716
2014 Q4	$10.1K	Hold	13	–	–	﹤0.01%	882
2014 Q3	$5.28K	Buy	+13	New	+$6.27K	﹤0.01%	1071

Other funds holding TCRT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Winslow Evans & Crocker's TCRT Position: Q3 2020 in Review

Winslow Evans & Crocker sold out of Alaunos Therapeutics (TCRT) in Q3 2020, closing a stake of 5 shares — an estimated $3K sold.

Winslow Evans & Crocker first reported a position in TCRT in Q3 2014 and held it in 20 quarters. The position peaked at $24K in Q2 2015. 154 funds tracked by Wall St. Rank hold TCRT as of Q3 2020.

Winslow Evans & Crocker reported no remaining Alaunos Therapeutics position as of Q3 2020 after selling out during the quarter.
Winslow Evans & Crocker sold 5 Alaunos Therapeutics shares in Q3 2020, an estimated $3K.
Winslow Evans & Crocker first reported a position in Alaunos Therapeutics in Q3 2014 and held it in 20 quarters.
Winslow Evans & Crocker's Alaunos Therapeutics position peaked at $24K in Q2 2015.
154 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2020.

Based on Winslow Evans & Crocker's 13F filing for Q3 2020, filed 21 Oct 2020.